We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.31% |
| 2 | Technology | 14.86% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Healthcare | 10.93% |
| 5 | Communication Services | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
Alnylam Pharmaceuticals
ALNY
$31.3B
| $1.08M | ﹤0.01% |
11,586
+6,793
| +142% | +$568K |
2018 Q2
3 quarters
|
|
802
AXIS Capital
AXS
$7.15B
| $1.08M | ﹤0.01% |
19,668
+5,244
| +36% | +$291K |
2017 Q3
6 quarters
|
|
|
BBBY
803
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.08M | ﹤0.01% |
63,345
+12,189
| +24% | +$184K |
2017 Q3
6 quarters
|
|
|
804
Amdocs
DOX
$6.34B
| $1.07M | ﹤0.01% |
19,807
-3,116,348
| -99% | -$175M |
2017 Q3
6 quarters
|
|
805
Dycom Industries
DY
$7.77B
| $1.06M | ﹤0.01% |
23,000
+5,800
| +34% | +$318K |
2018 Q2
3 quarters
|
|
806
Reliance Steel & Aluminium
RS
$20.8B
| $1.04M | ﹤0.01% |
11,564
+572
| +5% | +$47.7K |
2017 Q3
6 quarters
|
|
807
Brandywine Realty Trust
BDN
$453M
| $1.01M | ﹤0.01% |
63,921
+23,119
| +57% | +$349K |
2018 Q3
2 quarters
|
|
808
Genworth Financial
GNW
$3.38B
| $1M | ﹤0.01% |
260,574
+242,938
| +1,378% | +$1.06M |
2018 Q3
2 quarters
|
|
809
BlackRock TCP Capital
TCPC
$354M
| $993K | ﹤0.01% |
70,000
+17,000
| +32% | +$242K |
2018 Q4
1 quarter
|
|
810
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $992K | ﹤0.01% |
51,000
-10,400
| -17% | -$198K |
2018 Q2
3 quarters
|
|
|
TA
811
DELISTED
TravelCenters of America LLC
TA
| $986K | ﹤0.01% |
48,000
| – | – |
2018 Q2
3 quarters
|
|
812
New Mountain Finance
NMFC
$651M
| $971K | ﹤0.01% |
71,500
+9,000
| +14% | +$123K |
2018 Q2
3 quarters
|
|
|
CDK
813
DELISTED
CDK Global, Inc.
CDK
| $970K | ﹤0.01% |
16,482
+9,853
| +149% | +$537K |
2018 Q2
3 quarters
|
|
814
Carlyle Secured Lending
CGBD
$733M
| $960K | ﹤0.01% |
66,250
+32,500
| +96% | +$478K |
2018 Q4
1 quarter
|
|
815
Atlassian
TEAM
$55B
| $947K | ﹤0.01% |
+8,430
| New | +$861K |
2019 Q1
0 quarters
|
|
816
Ryder
R
$9.21B
| $919K | ﹤0.01% |
14,829
+1,705
| +13% | +$99.8K |
2017 Q3
6 quarters
|
|
817
Core Laboratories
CLB
$449M
| $915K | ﹤0.01% |
13,275
| – | – |
2017 Q3
6 quarters
|
|
|
OCSI
818
DELISTED
Oaktree Strategic Income Corporation
OCSI
| $908K | ﹤0.01% |
112,000
+15,000
| +15% | +$125K |
2018 Q3
2 quarters
|
|
819
AutoNation
AN
$5.28B
| $900K | ﹤0.01% |
25,200
+5,032
| +25% | +$182K |
2017 Q3
6 quarters
|
|
|
MNK
820
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $899K | ﹤0.01% |
+41,363
| New | +$882K |
2019 Q1
0 quarters
|
|
821
Corporacion America
CAAP
$4.03B
| $888K | ﹤0.01% |
107,400
+19,400
| +22% | +$147K |
2018 Q2
3 quarters
|
|
822
Booz Allen Hamilton
BAH
$8.96B
| $883K | ﹤0.01% |
15,194
-26,946
| -64% | -$1.4M |
2017 Q3
6 quarters
|
|
|
ESV
823
DELISTED
Ensco Rowan plc
ESV
| $880K | ﹤0.01% |
55,955
-14,606
| -21% | -$255K |
2017 Q3
6 quarters
|
|
824
Terreno Realty
TRNO
$6.97B
| $868K | ﹤0.01% |
20,641
-3,434
| -14% | -$137K |
2018 Q2
3 quarters
|
|
825
Murphy USA
MUSA
$9.9B
| $849K | ﹤0.01% |
9,919
-13,106
| -57% | -$1.04M |
2017 Q3
6 quarters
|
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.